K977-0271 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

K977-0271 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide
K977-0271 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K977-0271
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K977-0271

Molecular Formula

C25H28FN3O4S (C25 H28 FN3 O4 S)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-{[(4-fluorophenyl)methanesulfonyl]methyl}-3-oxo-1234-tetrahydroquinoxaline-6-carboxamide

SMILES

O=C(c(cc1)cc(N2)c1NC(CS(Cc(cc1)ccc1F)(=O)=O)C2=O)NCCC1=CCCCC1

InChI

InChI=1S/C25H28FN3O4S/c26-20-9-6-18(7-10-20)15-34(32,33)16-23-25(31)29-22-14-19(8-11-21(22)28-23)24(30)27-13-12-17-4-2-1-3-5-17/h4,6-11,14,23,28H,1-3,5,12-13,15-16H2,(H,27,30)(H,29,31)/t23-/m0/s1

InChI Key

FWBMTWRVMYRJED-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD15115559

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

485.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.638

Distribution Coefficient, logD

2.638

Water Solubility, LogSw

-3.14

Polar Surface Area

89.845

Acid Dissociation Constant (pKa)

10.45

Base Dissociation Constant (pKb)

-1.12

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.00

K977-0271 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with K977-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K977-0271?
Check Price and Availability of K977-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K977-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K977-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K977-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K977-0271 available by request